
Low T, High Stakes: What Every Man Needs to Know About Testosterone Therapy in 2025
In 2025, clinics like AlphaMan, a men's health center specializing in hormone optimization, are rethinking how testosterone therapy fits into modern masculinity. Because when it comes to low testosterone, the stakes extend far beyond the gym. Even high-performing men balancing careers, families, and fitness can find themselves battling unexplained fatigue, diminished focus, low libido, and persistent sluggishness despite adequate rest.
Welcome to the quiet crisis no one told you about: Low testosterone.
Once dismissed as a rare condition affecting older men, low T (testosterone deficiency) is now understood as a far more widespread issue. Thanks to a mix of modern stress, environmental exposures, and plain old aging, more men are hitting their 40s and 50s feeling like shadows of themselves — and many don't even know why.
Enter Testosterone Replacement Therapy (TRT). Equal parts buzzword and controversy, it's one of the most Googled men's health treatments of the last five years. But is it right for you? Is it safe? Or is it just hype with a syringe?
Testosterone isn't just about muscles and sex drive. It's a major player in everything from mood to memory to motivation. It supports bone density, fat distribution, red blood cell production, and sperm development. And when your levels are low? You feel it. 'Testosterone levels in men have been steadily declining over the past few decades,' says Suzie Pemdejian, head nurse practitioner at AlphaMan Clinic, a Los Angeles-based practice specializing in hormone health. 'The average man today has significantly lower levels than men in the 1980s, even when adjusted for age.'
And The Journal of Clinical Endocrinology & Metabolism has confirmed a marked decline in testosterone across American men over the past 20 years, so if you're feeling fatigued, unfocused, irritable, or like your sex drive has flatlined, you're not crazy. You might just have low T.
Low testosterone, or male hypogonadism, doesn't always announce itself with flashing neon lights. It can show up subtly — and men often write it off as 'just getting older.'
According to the Cleveland Clinic, common symptoms include:
If these sound familiar, it might be time to look under the hood.
One of the biggest misconceptions about TRT is that it's something you just hop on when you feel tired. That's not how any responsible clinic operates. 'We start with bloodwork,' says Dr. Allen Lawrence, who brings over 35 years of hormone therapy experience to AlphaMan Clinic. 'We run a full hormone panel and go deep into symptoms, lifestyle, and history. Low T isn't diagnosed from symptoms alone, and it's not just about hitting a number.'
Generally, total testosterone levels below 300 ng/dL (nanograms per deciliter) may indicate low T, but it's nuanced. Free testosterone (the active form) also matters, as does the patient's overall health picture.
Let's set the record straight.
Testosterone Replacement Therapy is not:
TRT is:
'TRT isn't a performance enhancer,' says Pemdejian. 'It's about bringing levels back to where they should be. When done right, it helps men regain energy, mental clarity, and emotional stability, all without the side effects people fear.'
The stigma around testosterone therapy runs deep. Ask most men what they think TRT does, and you'll get a mix of 'makes you angry' or 'it's just for bodybuilders.'
'One of the biggest myths is that TRT makes men aggressive or turns them into someone they're not,' Pemdejian says. 'That's simply not true when it's prescribed and monitored correctly.'
What about fertility? Yes, TRT has been said to lower sperm count, especially if taken without precautions. That is one reason why some men are prescribed hCG (human chorionic gonadotropin) alongside TRT to maintain testicular function and fertility potential.
And if you're worried it's not 'natural' to take hormones? Think about this:
'If your thyroid was underproducing, you'd take thyroid hormone. Testosterone is no different,' Lawrence says.
There's a right way to do TRT, and then there's the internet clinic way. (Spoiler: don't do that.)
Responsible providers follow safety protocols, like:
Harvard Health emphasizes that TRT should be tailored to the individual and revisited frequently to minimize risks and optimize outcomes.
Here's the deal: TRT can help, but it's not a license to live off cheeseburgers and whiskey.
Obesity, lack of sleep, stress, and poor nutrition can all tank testosterone levels. Regular exercise, weight loss, clean eating, and managing sleep hygiene can go a long way in restoring natural production or enhancing the benefits of TRT if you're on it.
'We never just give you testosterone and send you on your way,' Pemdejian explains. 'We look at the whole picture. Because real wellness isn't just hormonal.'
One under-discussed aspect of low testosterone? Its effect on mental health. Studies suggest that low T is associated with increased rates of depression, anxiety, and cognitive decline in aging men. 'When you don't feel like yourself, it affects everything—your work, your marriage, your confidence,' Lawrence notes. 'We've seen men come in feeling hopeless, and after a few months of proper care, they're totally renewed.'
The science backs that up. A 2020 meta-analysis found that TRT significantly improved depressive symptoms in men with low testosterone.
Still think testosterone therapy turns guys into roid-raging gym rats? You're not alone. One of the most persistent myths around TRT is that it makes men overly aggressive or 'unnatural.' The reality? When done right, it's the opposite.
'TRT isn't about turning you into a bodybuilder,' Pemdejian adds. 'It's about bringing your hormones back into a healthy, balanced range—so you can feel like yourself again.'
Here's the truth: Testosterone levels in men have been steadily dropping for decades, and not just with age. One peer-reviewed study found that average T levels in men today are substantially lower than in the 1980s, even after accounting for aging and other health factors. Translation? More men are feeling drained, foggy, and disconnected, and they don't always know why.
But here's the catch: not every guy with low energy or a sluggish sex drive needs testosterone therapy. That's why a legit clinic won't just hand you a vial and a syringe. At AlphaMan, it starts with comprehensive bloodwork, a detailed symptom profile, and a full lifestyle and medical history review.
'Low testosterone isn't diagnosed from symptoms alone, and it's not about chasing a magic number,' says Pemdejian. 'We're looking for patterns. We connect lab data to what you're actually experiencing day to day.'
Here's your modern man's checklist:
If that sounds like you, it might be time to start a conversation with a hormone specialist, not a fitness influencer.'You don't have to just accept decline as inevitable,' Pemdejian says. 'Men deserve to feel strong, clear-headed, and connected to themselves again.'
Testosterone therapy isn't about vanity. It's not about cheating aging, or becoming the next action movie hero. It's about getting back to the man you know you are.
The bottom line? TRT, when done responsibly, can be a game-changer. Not a quick fix, but a cornerstone in a broader strategy for staying vital, focused, and resilient well into your 50s, 60s, and beyond.
Click here for more information on Alphaman Clinic
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Journals
17 minutes ago
- Business Journals
The Pearl launches in Charlotte as a blueprint for health care transformation
The Pearl has officially opened its doors, marking the launch of a transformative new model in health care. Strategically uniting leading-edge medical training, academia and the most innovative names in health technology, The Pearl is designed to ignite collaboration, catalyze economic growth and drive innovative solutions for the city, region and beyond. The Charlotte-based innovation district was created by a visionary public-private partnership led by Atrium Health, Wexford Science & Technology, LLC and Ventas. Home to the Charlotte campus of Wake Forest University School of Medicine, the city's first four-year medical school, and the exclusive North American headquarters of IRCAD, a global network of advanced surgical training facilities, The Pearl will be a global destination for medical education and research. 'We built The Pearl to unlock the next era of clinical breakthroughs by uniting the brightest minds with the most advanced technologies in modern medicine,' said Eugene A. Woods, CEO of Advocate Health, of which Atrium Health is a part. 'It's where the world's top medical technology companies will work alongside surgeons, scientists, startups and students from Charlotte's first four-year medical school with the singular goal of finding new treatments and cures. Simply put, it will be a place where excellence lives — and excellence is learned.' Over the next 15 years, the district is projected to generate more than 5,500 on-site jobs and more than 11,500 total jobs across the region, making The Pearl a catalyst for economic growth and opportunity. 'Building vibrant, amenity-rich communities that spark innovation begins by bringing together visionary people and transformative ideas,' said Thomas Osha, executive vice president of Wexford Science & Technology, the developer of The Pearl. 'Grounded in research, discovery, entrepreneurship, corporate partnership and deep community engagement, The Pearl is more than a district — it's the beginning of a bold new chapter in Charlotte's innovation story.' At the heart of The Pearl is the Charlotte campus of Wake Forest University School of Medicine. The school of medicine is the academic core of Advocate Health. With its first class of students starting in July, enrollment is expected to increase to 100 students per class over the next five years. 'Complete with a state-of-the-art simulation center, we're reimagining education at Wake Forest University School of Medicine for the next generation of medical professionals,' said Dr. Julie Freischlag, chief academic officer of Advocate Health and CEO of Atrium Health Wake Forest Baptist. 'By integrating traditional learning with real-world experience and community engagement, The Pearl fosters an environment where learning extends far beyond the classroom.' Appealing to different learning styles, the school of medicine's Charlotte campus curriculum takes a unique, problem-based approach to learning, known as integrated biomedical sciences. The approach uses weekly clinical cases as springboards for students to learn foundational science and evaluate possible diagnoses, in addition to considering outside factors that may impact patient outcomes. The Pearl also is home to IRCAD North America, which includes a surgical training curriculum with the latest techniques in cardiovascular, neuro and orthopedic surgeries, among others, all of which are unique to the network. With programs set to begin in September, it's expected to draw thousands of medical professionals from across the globe annually. 'I congratulate Advocate Health on the grand opening of The Pearl, which will help provide lifesaving care to the Charlotte community and foster cutting-edge medical innovation,' said North Carolina Gov. Josh Stein. 'With an estimated 5,500 onsite jobs, The Pearl will also be a boon to Charlotte's economy, strengthen North Carolina's health care network and position our state as a global destination for advancing complex medical care.' The commitment to educating the next generation of medical professionals also is evident through Atrium Health's partnership with Charlotte-Mecklenburg Schools. Together, with support from other partners, they've launched a science, technology, engineering and mathematics — or STEM — program designed to help middle school students get excited about careers in health care through free learning opportunities in an on-site lab. 'This innovation district is a powerful symbol of Charlotte's commitment to creating opportunities for everyone who calls this city home,' said Charlotte Mayor Vi Lyles. 'Not only does it honor our past by recognizing the rich history of Brooklyn, but it also looks to create space for inclusive growth.' Located in the area historically known as Brooklyn — once a thriving African American community that was displaced in the 1960s and 1970s — the district is designed to reflect that legacy of resilience. With exhibits that pay homage to Brooklyn's enduring legacy, The Pearl aims to be a place where people from all walks of life will feel welcome and grow together. 'This is an important milestone for our entire community,' said Mark Jerrell, chair of the Mecklenburg Board of County Commissioners. 'This investment has the potential to foster greater opportunities for our residents, scholars and workforce in a way that honors this community's rich history, while also paving the way for a brighter future.' The grand opening, which marked the completion of the first of three phases and includes more than 700,000 square feet of space, included walking tours, performances by local artists, a showcase of community partners and exhibits that reflect both the technological aspirations and the cultural heritage of the neighborhood. National excitement: What others are saying Sen. Phil Berger, North Carolina Senate President Pro Tempore: 'The Pearl is more than an innovation district in Charlotte — it's a launchpad for North Carolina's future. By attracting world-class partners like Wake Forest University School of Medicine and IRCAD North America, as well as investing in cutting-edge innovation, The Pearl is driving economic growth, expanding opportunity and helping shape a healthier, more prosperous state. Its impact will stretch far beyond city limits — fueling talent, research and progress that benefits all North Carolinians.' Dr. L. Ebony Boulware, dean of Wake Forest University School of Medicine, chief science officer and vice chief academic officer of Advocate Health: 'As our world is changing, especially with technology advances, we are challenged to rethink everything — how we teach, how students learn and how we prepare the next generation of physicians to lead. This challenge became an opportunity. And our new school of medicine campus at The Pearl is our answer. This is a place where medicine meets technology, where education meets entrepreneurship — and where talent becomes transformation.' Rep. Destin Hall, North Carolina House of Representatives Speaker: 'The Pearl stands as one of North Carolina's most significant investments in decades, delivering profound impacts both economically and in human health. By bringing Wake Forest's world-class medical school and its partnership with Atrium Health to Charlotte, they are addressing the state's critical health care needs while generating substantial economic growth and opportunity.' John Kowal, president and head of the Americas at Siemens Healthineers: 'North Carolina is an increasingly important location for our business. The combination of IRCAD North America, Wake Forest University School of Medicine Charlotte and our U.S. Experience Center within The Pearl makes it the ideal site for innovation, collaboration and improved patient care.' Sen. Thom Tillis, United States Senate: 'The launch of The Pearl represents a transformative milestone for Charlotte and the entire state of North Carolina. By uniting institutions like Atrium Health, Wake Forest Baptist Health and Wake Forest University School of Medicine, this innovation district will advance groundbreaking research, generate economic growth and further elevate North Carolina's role as a national leader in science, medicine and technology.' Dr. Dionisios Vrochides, Executive Director of IRCAD North America: 'We're at the forefront of a new era in surgical education, driven by medical robotics, augmented reality, telepresence and AI. With IRCAD North America being part of The Pearl, we're creating a global ecosystem where innovation meets precision. Here, the world's brightest medical minds will converge to transform the future of minimally invasive surgery across every discipline.' Atrium Health Wake Forest Baptist is a pre-eminent academic learning health system based in Winston-Salem, North Carolina, and part of Advocate Health. Atrium Health Wake Forest Baptist's two main components are an integrated clinical system with locations throughout the region and , the academic core of Advocate Health and a recognized leader in experiential medical education and groundbreaking research.


Business Journals
21 minutes ago
- Business Journals
The GLP-1 weight loss debate: Pharmacy benefit leaders weigh in on difficult coverage decisions
Employers are grappling with the ripple effect of an increasingly popular weight loss treatment. Glucagon-like peptide 1 (GLP-1) receptor agonists are a favored treatment for type-2 diabetes but have also become incredibly popular for treating obesity. One in eight U.S. adults have taken GLP-1 medication, according to a KFF Health Tracking Poll, with one in three saying they've heard a lot about them. Usage is growing so fast Goldman Sachs estimates the drugs could push the global market for anti-obesity medications to $100 billion in annual sales by 2030. The challenge for employers is the cost. According to the National Conference of State Legislatures, GLP-1s have an average annual list price of $12,000. Because patients tend to regain weight when they discontinue treatment, the cost of coverage is high. 'GLP-1s are a topic that comes up in almost every client meeting,' said Shanda Harclerode, a pharmacist and pharmacy consultant for Holmes Murphy's employee benefits group. 'Across the board, we're seeing it in the top three drugs in terms of plan spend.' Among Holmes Murphy's employee benefits clients, spending on GLP-1s increased 36% from 2023 to 2024, Harclerode said. The treatments represented 17% of all pharmaceutical spending in 2024 and 4% of medical and pharmacy spending combined. Understanding the market for obesity treatments The appeal for an injectable treatment for obesity is easy to understand, said Nathan Cassin, employee benefits pharmacy director with Holmes Murphy. 'Obesity affects 42% of American adults and that number is rising and these drugs are revolutionary in terms of managing weight,' Cassin said. You have to go back several decades to find new medication releases with this wide of an impact, Cassin said, pointing to Zoloft's approval for mental health conditions in 1991, Lipitor's approval for lowering cholesterol in 1996 and Nexium's approval for reducing stomach acid in 2001. The broad market for obesity treatments has helped spur interest in GLP-1s from many drug manufacturers. There is a robust pipeline of GLP-1 products undergoing clinical trials for obesity treatment and manufacturers are starting to sell the drugs directly to members through telehealth appointments. However, Harclerode said this increased competition will not reduce employers' expenses anytime soon. 'While we may see some of the pricing of the drugs come down as competition increases with new agents coming to market and more competition between the different manufacturers to get their products on the formulary,' she said, 'anticipated increases in utilization are likely going to offset any pricing relief. GLP-1s and similar molecules are currently being studied for a variety of other applications, including Alzheimer's disease, osteoarthritis, and heart failure, significantly expanding their potential use going forward.' Employee benefit strategies for employers Employers are left with difficult choices. Harclerode recommends business leaders start by assessing how GLP-1s fit the needs of their employees. Ask these questions: What is the prevalence of obesity and related conditions within my population? What can we expect in terms of utilization? How much would that utilization cost? Does that cost fit within our employee benefits budget? What is my employee turnover rate? Given that, will our plan realize the potential future benefits that come with weight loss? How important is offering this coverage to our talent attraction and retention efforts? Employers that decide to offer GLP-1 coverage should make sure to design their program in a way that maximizes its effectiveness, Harclerode said. Some clients require people to participate in wellness programs — such as working with a health coach or dietitian — to be eligible for GLP-1 therapies. 'Since these drugs require long-term use for sustained benefits, we want to ensure that if a member stops their GLP-1 therapy, the appropriate behavioral changes have been adopted to maintain the weight loss that was achieved while on the medication,' she said. Because of their popularity, businesses that opt not to cover GLP-1s may want to be transparent with employees about why and what they're doing to support weight loss instead, Harclerode said. They won't be alone. In a 2024 Business Group on Health survey, 67% of large employers reported covering GLP-1s, while only 28% of Holmes Murphy's clients — including many businesses with less than 10,000 people — provide the coverage. 'I don't think there's a one-size-fits-all approach,' Harclerode said. Are you getting the most out of your employer-sponsored pharmacy benefits? From pricing terms and contracts to understanding clinical programs, Holmes Murphy can help. As one of the largest independent insurance brokerages in the nation, Holmes Murphy believes fully in serving the unique risk and benefits challenges of clients in every industry and of almost every size. For more information, visit or follow the company on X (@holmesmurphyins), Facebook, LinkedIn, or Instagram.
Yahoo
35 minutes ago
- Yahoo
Olivia Munn says she learned to let go of her 'extra baggage' after her breast cancer diagnosis
Olivia Munn says her breast cancer diagnosis taught her to let go of the "extra baggage" in her life. "When I got the diagnosis, immediately, the negative thoughts in my head, I dropped all of that," she said. Despite being more common in middle-aged and older women, breast cancer is rising among women under 50. Olivia Munn, 44, says her breast cancer diagnosis forced her to confront her priorities in life. On Monday's episode of "Armchair Expert with Dax Shepard," Munn spoke about how her cancer journey prompted her to let go of distractions and focus on the things she truly cared about. The "X-Men: Apocalypse" actor was diagnosed with breast cancer and underwent a double mastectomy in 2023. "When I got the diagnosis, immediately, the negative thoughts in my head, I dropped all of that. Because when you are diagnosed with cancer you have one job," Munn told podcast host Dax Shepard. Munn said her sole focus at that point in time became recovery, and with all her energy dedicated to surviving cancer, she had no room to think about anything else. "That's all your mind is thinking about, and you're like 'How do I get through this? How do I get through this? How do I live? How do I survive?' Because there's no way to climb Everest with extra baggage on your shoulders," Munn said. When she recovered, she realized the experience had completely changed her mindset. "I'm like, oh, now that I got to the other side, I'm not going to — I can't imagine picking it back up," Munn said. "That's what cancer did for me," she added. "It was literally one step at a time, right, so when I have the thoughts that creep in, I think very quickly and let it go." Munn isn't the only public figure who has publicly spoken about their cancer journey. In April 2024, Shannen Doherty had said on her podcast that she was getting rid of some of her belongings after her breast cancer returned as stage 4. Doherty died in July 2024 at 53. In November, Kathy Bates said that she decided against having reconstruction surgery after getting a double mastectomy in 2012 due to breast cancer. In the US, breast cancer accounts for about 30% of all new cancer diagnoses in women each year, per data from the American Cancer Society. Although breast cancer mainly occurs in middle-aged and older women, the disease is on the rise among those who are 50 and below. A representative for Munn did not immediately respond to a request for comment sent by Business Insider outside regular hours. Read the original article on Business Insider